Impact of apoptotic circulating tumor cells (aCTC) in metastatic breast cancer.
Thomas M DeutschSabine RiethdorfJuliane NeesAndreas D HartkopfBirgitt SchönfischChristoph DomschkeMartin R SprickFlorian SchützSara Y BruckerStefan StefanovicChristof SohnKlaus PantelAndreas TrumppAndreas SchneeweissMarkus WallwienerPublished in: Breast cancer research and treatment (2016)
Intact and aCTC are predictive of outcome in MBC. Apoptotic CTC counts ≥ 5/7.5 ml in conjunction with iCTC at baseline have an independent unfavorable prognostic impact on OS. Decreasing aCTCKIN at ≥ 5/7.5 ml in serial enumeration is associated with favorable outcome. Therefore, separate enumeration of iCTC and aCTC is useful in tailoring systemic treatment.